Journal
TUMOR BIOLOGY
Volume 39, Issue 7, Pages -Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1010428317706430
Keywords
MicroRNAs; lung cancer; therapeutic strategy; biomarker; bioinformatics; microRNA-target interaction
Categories
Funding
- IZKF Wurzburg [BD-247]
- BMBF [031L0129B]
- University of Wuerzburg
Ask authors/readers for more resources
MicroRNAs are well-known strong RNA regulators modulating whole functional units in complex signaling networks. Regarding clinical application, they have potential as biomarkers for prognosis, diagnosis, and therapy. In this review, we focus on two microRNAs centrally involved in lung cancer progression. MicroRNA-21 promotes and microRNA-34 inhibits cancer progression. We elucidate here involved pathways and imbed these antagonistic microRNAs in a network of interactions, stressing their cancer microRNA biology, followed by experimental and bioinformatics analysis of such microRNAs and their targets. This background is then illuminated from a clinical perspective on microRNA-21 and microRNA-34 as general examples for the complex microRNA biology in lung cancer and its diagnostic value. Moreover, we discuss the immense potential that microRNAs such as microRNA-21 and microRNA-34 imply by their broad regulatory effects. These should be explored for novel therapeutic strategies in the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available